Virios Therapeutics Stock Plunges 70% on Fibromyalgia Clinical Trial Failure Results
In a shocking failure, Virios Therapeutics announced this morning pre-market that topline results from its FORTRESS (Fibromyalgia Outcome…
Browsing Tag